PATENT CLAIM ANALYSIS

Application Number: 16408602
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-08
Patent Classification: ["530", "391900"]

Abstract:
Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.

Claim (Index 1):
A compound: wherein n is 4, and A is an antibody comprising SEQ ID NO: 66 and SEQ ID NO:73.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 100.0
- Lexical Diversity: 1.21739
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15301564', '14772731', '15676726', '13883713', '14817455']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6235768634134317
- 35 USC 102 Novelty (BERT): 0.5424889382930093
- Combined Prediction Score: 0.6154680709013893
- Mean Citation Score: 211.869348
- Max Citation Score: 276.72116
- Similarity Product: 152.89639358264446

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test